Who is sponsoring NCT05115032?

NCT05115032 is sponsored by Eytan A. David.

What condition does NCT05115032 study?

NCT05115032 studies Dizziness, Equilibrium; Disorder, Labyrinth, Inner Ear Injury, Inner Ear Disease.

Is NCT05115032 still recruiting?

NCT05115032 is currently completed. Last updated 10 April 2025.

Last reviewed 2025-04-10 · How we verify

NCT05115032

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Posturography-assisted Vestibular Retraining for Stable Unilateral Vestibular Deficit

Completed NA Last updated 10 April 2025

What this trial tests

NA trial testing Vestibular retraining with dynamic posturography in Dizziness in 37 participants. Completed in 19 April 2023.

Timeline

17 January 2022

Primary endpoint
15 December 2022

19 April 2023

Quick facts

Lead sponsor	Eytan A. David
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	37
Start date	17 January 2022
Primary completion	15 December 2022
Estimated completion	19 April 2023
Sites	1 location across Canada

Drugs / interventions tested

Vestibular retraining with dynamic posturography
At-home rehabilitation exercises

Conditions studied

Dizziness — all drugs for Dizziness →
Equilibrium; Disorder, Labyrinth — all drugs for Equilibrium; Disorder, Labyrinth →
Inner Ear Injury — all drugs for Inner Ear Injury →
Inner Ear Disease — all drugs for Inner Ear Disease →

Sponsor

Eytan A. David

Who can join

Adults 18 to 80, any sex, with Dizziness or Equilibrium; Disorder, Labyrinth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People that have difficulty with balance have a higher risk of falling and reduced quality of life. Some individuals can learn to compensate using their vision, their sense of where their limbs are in space, and balance organs that are still intact. Rehabilitation exercises, which typically involve shaking and nodding of the head, are often prescribed for dizzy patients but are not effective for everyone. Our study aims to determine if specific exercises performed on footplate sensors with visual feedback is superior to traditional rehabilitation exercises done at home for improving balance and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Vestibular Rehabilitation Using Dynamic Posturography: Functional Stability and Fall Risk Outcomes From a Randomized Trial.
David EA, Shahnaz N, Wiseman I, David Y, et al · · 2025 · cited 1× · PMID 40624853 · DOI 10.1002/ohn.1302

Verify or expand the search:

Other recruiting trials for Dizziness

Currently open trials in the same condition.

NCT07225023 — A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness · NA · recruiting
NCT06893029 — Dizziness Due to Visual Stimuli in Patients With Concussion and Other Causes of Dizziness: Examination of Balance Behavi · NA · recruiting
NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
NCT06222450 — Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI · NA · recruiting
NCT07099222 — Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks · Phase 1, PHASE2 · active not recruiting

Other Eytan A. David trials

Trials by the same sponsor.

NCT04875013 — Interactive Rehabilitation for Adults With Unilateral Vestibular Weakness · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05115032 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eytan A. David
Last refreshed: 10 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05115032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing